Eliana Merle
Stock Analyst at Barclays
(3.04)
# 2,653
Out of 4,988 analysts
414
Total ratings
44.6%
Success rate
2%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Eliana Merle
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Reiterated: Buy | $85 | $44.44 | +91.27% | 25 | Sep 18, 2026 | |
| FDMT 4D Molecular Therapeutics | Reiterated: Buy | $33 → $28 | $15.22 | +83.97% | 2 | Sep 11, 2026 | |
| TYRA Tyra Biosciences | Reiterated: Buy | $59 | $25.73 | +129.30% | 9 | Sep 10, 2026 | |
| SGMT Sagimet Biosciences | Upgraded: Buy | $8 → $18 | $11.09 | +62.31% | 5 | Sep 9, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Buy | $43 → $32 | $14.51 | +120.54% | 7 | Sep 3, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $450 | $239.56 | +87.84% | 17 | Sep 1, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $157 | $66.61 | +135.70% | 21 | Aug 31, 2026 | |
| MRNA Moderna | Reiterated: Hold | $48 → $125 | $154.04 | -18.85% | 32 | Aug 24, 2026 | |
| BMRN BioMarin Pharmaceutical | Reiterated: Buy | $105 → $111 | $63.94 | +73.60% | 42 | Aug 17, 2026 | |
| ALT Altimmune | Reiterated: Buy | $20 | $3.25 | +515.38% | 8 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $345 → $329 | $236.72 | +38.98% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $122 | $65.37 | +86.63% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $237 | $120.00 | +97.50% | 8 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $88 | $62.91 | +39.88% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $12 | $8.03 | +49.44% | 6 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $3.51 | +270.37% | 2 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $20.11 | -0.55% | 12 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $133 → $139 | $117.75 | +18.05% | 12 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $917 | $784.85 | +16.84% | 5 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $615 → $617 | $508.34 | +21.38% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $964 → $962 | $531.52 | +80.99% | 15 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 → $60 | $44.00 | +36.36% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $22 → $0.28 | $10.73 | -97.39% | 14 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $3.78 | +376.19% | 4 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $115 → $117 | $96.06 | +21.80% | 25 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $20 | $55.20 | n/a | 25 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $96 → $112 | $150.11 | n/a | 3 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $63 → $12 | $66.48 | n/a | 3 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.91 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $74 → $21 | $8.29 | n/a | 12 | May 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $2.2 | $3.11 | n/a | 6 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $71 | $190.95 | n/a | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $5 | $32.71 | n/a | 3 | Apr 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $12.13 | n/a | 1 | Oct 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $8.03 | n/a | 3 | Mar 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $192 → $134 | $28.55 | n/a | 10 | Aug 19, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $1.83 | n/a | 8 | Dec 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.20 | n/a | 4 | Mar 18, 2019 |
Ionis Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $85
Current: $44.44
Upside: +91.27%
4D Molecular Therapeutics
Sep 11, 2026
Reiterated: Buy
Price Target: $33 → $28
Current: $15.22
Upside: +83.97%
Tyra Biosciences
Sep 10, 2026
Reiterated: Buy
Price Target: $59
Current: $25.73
Upside: +129.30%
Sagimet Biosciences
Sep 9, 2026
Upgraded: Buy
Price Target: $8 → $18
Current: $11.09
Upside: +62.31%
Ultragenyx Pharmaceutical
Sep 3, 2026
Reiterated: Buy
Price Target: $43 → $32
Current: $14.51
Upside: +120.54%
Alnylam Pharmaceuticals
Sep 1, 2026
Reiterated: Buy
Price Target: $450
Current: $239.56
Upside: +87.84%
BridgeBio Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $157
Current: $66.61
Upside: +135.70%
Moderna
Aug 24, 2026
Reiterated: Hold
Price Target: $48 → $125
Current: $154.04
Upside: -18.85%
BioMarin Pharmaceutical
Aug 17, 2026
Reiterated: Buy
Price Target: $105 → $111
Current: $63.94
Upside: +73.60%
Altimmune
Aug 13, 2026
Reiterated: Buy
Price Target: $20
Current: $3.25
Upside: +515.38%
Aug 13, 2026
Reiterated: Buy
Price Target: $345 → $329
Current: $236.72
Upside: +38.98%
Aug 13, 2026
Reiterated: Buy
Price Target: $120 → $122
Current: $65.37
Upside: +86.63%
Aug 7, 2026
Reiterated: Buy
Price Target: $237
Current: $120.00
Upside: +97.50%
Aug 7, 2026
Reiterated: Buy
Price Target: $70 → $88
Current: $62.91
Upside: +39.88%
Aug 7, 2026
Downgraded: Hold
Price Target: $12
Current: $8.03
Upside: +49.44%
Aug 7, 2026
Reiterated: Buy
Price Target: $13
Current: $3.51
Upside: +270.37%
Aug 7, 2026
Reiterated: Hold
Price Target: $20
Current: $20.11
Upside: -0.55%
Aug 6, 2026
Reiterated: Buy
Price Target: $133 → $139
Current: $117.75
Upside: +18.05%
Aug 5, 2026
Reiterated: Buy
Price Target: $917
Current: $784.85
Upside: +16.84%
Aug 5, 2026
Reiterated: Buy
Price Target: $615 → $617
Current: $508.34
Upside: +21.38%
Aug 3, 2026
Reiterated: Buy
Price Target: $964 → $962
Current: $531.52
Upside: +80.99%
Jul 30, 2026
Reiterated: Buy
Price Target: $65 → $60
Current: $44.00
Upside: +36.36%
Jul 28, 2026
Reiterated: Sell
Price Target: $22 → $0.28
Current: $10.73
Upside: -97.39%
Jun 4, 2026
Reiterated: Buy
Price Target: $18
Current: $3.78
Upside: +376.19%
Nov 6, 2025
Reiterated: Hold
Price Target: $115 → $117
Current: $96.06
Upside: +21.80%
Aug 12, 2025
Reiterated: Hold
Price Target: $33 → $20
Current: $55.20
Upside: n/a
Aug 8, 2025
Reiterated: Hold
Price Target: $96 → $112
Current: $150.11
Upside: n/a
Jul 21, 2025
Downgraded: Hold
Price Target: $63 → $12
Current: $66.48
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: $8
Current: $1.91
Upside: n/a
May 15, 2025
Reiterated: Buy
Price Target: $74 → $21
Current: $8.29
Upside: n/a
Jan 28, 2025
Reiterated: Hold
Price Target: $5 → $2.2
Current: $3.11
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $71
Current: $190.95
Upside: n/a
Apr 4, 2024
Reiterated: Hold
Price Target: $3 → $5
Current: $32.71
Upside: n/a
Oct 13, 2022
Initiated Coverage: Buy
Price Target: $22
Current: $12.13
Upside: n/a
Mar 3, 2021
Reiterated: Buy
Price Target: $10
Current: $8.03
Upside: n/a
Aug 19, 2020
Reiterated: Hold
Price Target: $192 → $134
Current: $28.55
Upside: n/a
Dec 11, 2019
Reiterated: Buy
Price Target: $40
Current: $1.83
Upside: n/a
Mar 18, 2019
Reiterated: Buy
Price Target: $8
Current: $4.20
Upside: n/a